Live from the NIH registry
Studies recruiting near Columbus right now
Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
IACT Health-Brookstone Centre Pkwy — Columbus, Georgia (7.3 mi)
· Sponsor: Sparrow Pharmaceuticals
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Type 1 Diabetes Mellitus
Phase 3
Interventional 723 participants sought
IACT Health - Columbus - Talbotton Road- Site Number : 8400003 — Columbus, Georgia (7.3 mi)
· Sponsor: Sanofi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Columbus Regional Research Institute — Columbus, Georgia (7.3 mi)
· Sponsor: Boehringer Ingelheim
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
Diabetes Mellitus, Type 1
Phase 3
Interventional 150 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: vTv Therapeutics
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
Primary Membranous Nephropathy
Phase 2, Phase 3
Interventional 176 participants sought
DaVita Clinical Research Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
NASH With Fibrosis, MASH With Fibrosis
Phase 3
Interventional 1,650 participants sought
Akero Clinical Study Site — Columbus, Georgia (7.3 mi)
· Sponsor: Akero Therapeutics, Inc
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Non Small Cell Lung Cancer
Phase 3
Interventional 780 participants sought
Centricity Research Columbus Cancer Center ( Site 0005) — Columbus, Georgia (7.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Locally Advanced Solid Tumors, Metastatic Solid Tumors
Phase 1, Phase 2
Interventional 500 participants sought
Local Institution - 2134 — Columbus, Georgia (7.3 mi)
· Sponsor: Turning Point Therapeutics, Inc.
A Study to Assess the Safety, Tolerability and Efficacy of ION775
Hypertriglyceridemia, Severe Hypertriglyceridemia
Phase 2
Interventional 72 participants sought
Ionis Investigative Site — Columbus, Georgia (7.3 mi)
· Sponsor: Ionis Pharmaceuticals, Inc.
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Liver Cirrhosis
Phase 2
Interventional 30 participants sought
Centricity Research Columbus Georgia Multispecialty — Columbus, Georgia (7.3 mi)
· Sponsor: Boehringer Ingelheim
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Locally Advanced Pancreatic Cancer
Phase 3
Interventional 190 participants sought
Piedmont-Columbus Regional - John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: RenovoRx
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Breast Cancer, Early Breast Cancer
Phase 3
Interventional 5,500 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Overweight, Obesity
Phase 3
Interventional 460 participants sought
Columbus Research Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Novo Nordisk A/S
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
Alzheimers Disease
Phase 3
Interventional 800 participants sought
Alzheimer's Research and Treatment Center - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Hoffmann-La Roche
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
Phase 3
Interventional 6,950 participants sought
Research Site — Columbus, Georgia (7.3 mi)
· Sponsor: AstraZeneca
AETOS Shoulder System
Shoulder Osteoarthritis, Shoulder Arthritis
N/A
Observational 220 participants sought
Hughston Foundation — Columbus, Georgia (7.3 mi)
· Sponsor: Smith & Nephew, Inc.
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 500 participants sought
John B Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
Centricity Research - Columbus — Columbus, Georgia (7.3 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
An Internet-based Program to Help Cancer Survivors Manage Pain
Cancer
N/A
Interventional 456 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Wake Forest University Health Sciences
Study of BHV-1300 in Graves' Disease
Graves Disease
Phase 1
Interventional 15 participants sought
Site-104 — Columbus, Georgia (7.3 mi)
· Sponsor: Biohaven Therapeutics Ltd.
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Advanced Non-small Cell Lung Cancer, HER2 Mutation
Phase 3
Interventional 555 participants sought
John B. Amos Cancer Center — Columbus, Georgia (7.3 mi)
· Sponsor: Bayer
Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects
Asthma
N/A
Observational 160 participants sought
AllerVie Clinical Research — Columbus, Georgia (7.3 mi)
· Sponsor: Biometry Inc
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
Triple Negative Breast Cancer
Phase 3
Interventional 657 participants sought
Columbus Regional Research Institute, LLC — Columbus, Georgia (7.3 mi)
· Sponsor: Jina Pharmaceuticals Inc.